551. Association of matrix metalloproteinase-3 gene 5A/6A polymorphism with the recurrence of ischemic stroke: A prospective observational study
- Author
-
Zusen Ye, Jia Li, Xin-Lei Mao, Siyan Chen, Yanyan Chen, Zheng Zhang, Zhenguo Zhu, Nian-Ge Xia, Qiang Ye, Xiang-Dong Huang, Xiaoya Huang, and Li-Ya Han
- Subjects
Male ,0301 basic medicine ,Matrix Metalloproteinase 3 ,China ,medicine.medical_specialty ,Pathology ,Polymorphism, Single Nucleotide ,Gastroenterology ,Brain Ischemia ,03 medical and health sciences ,0302 clinical medicine ,Asian People ,Gene Frequency ,Recurrence ,Internal medicine ,Genotype ,medicine ,Humans ,Genetic Predisposition to Disease ,In patient ,Prospective Studies ,Promoter Regions, Genetic ,Molecular Biology ,Gene ,Aged ,Chinese population ,business.industry ,Proportional hazards model ,General Neuroscience ,Cerebral Infarction ,Middle Aged ,Atherosclerosis ,Stroke ,030104 developmental biology ,Ischemic stroke ,Female ,Observational study ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Follow-Up Studies ,Developmental Biology - Abstract
Studies have demonstrated that matrix metalloproteinase-3 (MMP-3) is involved in the development and progression of atherosclerosis. However, there is no information available on the association of MMP-3 5A/6A polymorphism with recurrent ischemic stroke (IS) in different IS subtypes. We investigated the potential associations between MMP-3 serum level and -1171 5A/6A polymorphism and the recurrence of IS in a Chinese population. Consecutive acute first-ever IS patients were enrolled between August 2008 and October 2013. The genotypes of MMP-3 5A/6A polymorphism were determined using polymerase chain reaction-restriction fragment length polymorphism. IS recurrence was monitored after the index event and multivariate Cox proportional hazards model was constructed to identify factors related to future IS recurrence. A total of 1282 eligible patients were enrolled. During a 2-year follow-up period, 157 (12.25%) patients had recurrent events. MMP-3 level was significantly higher in patients with 5A/6A or 5A/5A genotype (22.72±7.29ng/ul) than in patients with 6A/6A genotype (20.48±7.58ng/ul), P0.001. No interaction between MMP-3 5A/6A polymorphism and the risk of recurrence in total IS patients was found. The variant 5A/6A+5A/5A genotype and the 5A allele were significantly associated with a high risk of recurrence for large-artery atherosclerosis (LAA) (multivariate-adjusted, P=0.002, 0.001, respectively), but not for small-artery occlusion and cardioembolism. Our finding showed that MMP-3 5A/6A may be a useful biomarker for predicting recurrence for LAA stroke patients and 5A allele carrier may bear a higher risk of recurrence among patients with the subtype of LAA.
- Published
- 2017
- Full Text
- View/download PDF